(1) the compounded semaglutide drugs are compounded drug products that have not been approved by the FDA; have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to FDA to be safe or effective for their intended use; (2) the processes by which the compounded drugs are manufactured have not been reviewed by the FDA; and (3) FDA-approved products containing semaglutide are available.
FOR MORE INFO AND TO DISCUSS WITH A HEALTH PRO, COMPLETE THE FORM BELOW…
Get Started with Semaglutide Treatments Today!
Semaglutide is a weekly injection that belongs to a class of drugs known as GLP-1 agonists which were originally developed to treat type 2 diabetes.
How does it work?
Semaglutide slows down gatrointestinal motility, causing patients to feel full, and acts on the appetite centers in the brain to decrease hunger. In other words, people who use this type of medication are able
to feel full with smaller portions and they are less hungry, which induces weight loss.
What are the side effects?
In some cases, people reported nausea, diarrhea, or constipation. However, gastrointestinal symptoms often times improve as patients get used to higher doses. We have medicine on hand to treat the side effects, so don’t despair or give up if you experience some discomfort in the first few weeks of treatment.
Who is eligible?
If you are ready to lose weight and you meet these criteria, then you may be a good candidate to begin taking Semaglutide.
1. BMI above 25
2. No personal or family history of thyroid cancer
3. Not currently taking other GLP-1 agonists, diabetic medications, or thyroid medications
4. No history of suicidal or homicidal ideations